Among many findings, GLP-1 use was associated with lower risk of Alzheimers disease and other neurological outcomes compared with usual care, with effect sizes varying by comparator drug class
What is mixed is its track record as a weight-loss aid: the evidence is inconsistent, absorption of some forms is limited, and the effects, when they appear, are modest
Inhibition of TMA Generation Choline TMA-lyase (CutC/CutD) and carnitine oxygenase (CntA) are several enzymes that involved in converting dietary compounds into TMA
Strategies to Minimize Side Effects During the First Month Eat small, frequent meals (every 23 hours) rather than three large ones to reduce nausea and prevent unintentional starvation
If it is almost time for the next dose, skip the missed one and continue with your normal schedule
Many studies suggest that Tirzepatide, a dual GIP/GLP-1 receptor agonist, is the most effective among these options for weight reduction